title: [Workup and treatment of autoimmune encephalitis].
abstract: Autoimmune encephalitis with antibodies against neuronal surface antigens is diagnosed with increasing frequency in recent years. If treated early and aggressively, these conditions often respond favourably to immunotherapy. We describe the clinical features, diagnosis and treatment of the two most common types of autoimmune encephalitis with antibodies against the N-methyl-D-aspartate receptor or the leucine-rich glioma-inactivated 1 protein. Together, these two conditions comprise 80% of the autoimmune encephalitis cases diagnosed in Denmark. Autoimmune encephalitides with rare antibodies are also summarized.
authors.affiliation: mortenblaabjerg1@rsyd.dk.
authors.forename: Morten
authors.initials: M
authors.lastname: Blaabjerg
authors.forename: Camilla C
authors.initials: CC
authors.lastname: Mærsk-Møller
authors.forename: Daniel
authors.initials: D
authors.lastname: Kondziella
authors.forename: Finn
authors.initials: F
authors.lastname: Somnier
authors.forename: Marko
authors.initials: M
authors.lastname: Celicanin
authors.forename: Henning
authors.initials: H
authors.lastname: Andersen
authors.forename: Flemming W
authors.initials: FW
authors.lastname: Bach
authors.forename: Lars H
authors.initials: LH
authors.lastname: Pinborg
mesh_terms: D060426:Anti-N-Methyl-D-Aspartate Receptor Encephalitis / Q000175:diagnosis / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy; D019091:Critical Pathways; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007165:Immunosuppression Therapy; D020363:Limbic Encephalitis / Q000175:diagnosis / Q000188:drug therapy